Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 13, 2017	SC 13G/A	An amendment to the SC 13G filing	0001193125-17-039994.pdf 0001193125-17-039994.rtf 0001193125-17-039994.xls View HTML
February 14, 2017	SC 13G/A	An amendment to the SC 13G filing	0000315066-17-001401.pdf 0000315066-17-001401.rtf View HTML
March 6, 2017	SC 13G/A	An amendment to the SC 13G filing	0000790502-17-000002.pdf 0000790502-17-000002.rtf View HTML
November 7, 2017	SC 13G/A	An amendment to the SC 13G filing	0001104659-17-066647.pdf 0001104659-17-066647.rtf 0001104659-17-066647.xls View HTML
January 8, 2018	SC 13G/A	An amendment to the SC 13G filing	0000790502-18-000001.pdf 0000790502-18-000001.rtf View HTML
January 29, 2018	SC 13G/A	An amendment to the SC 13G filing	0000215457-18-003721.pdf 0000215457-18-003721.rtf View HTML
February 14, 2018	SC 13G/A	An amendment to the SC 13G filing	0001144204-18-008432.pdf 0001144204-18-008432.rtf 0001144204-18-008432.xls View HTML
August 31, 2018	SC 13G/A	An amendment to the SC 13G filing	0000790502-18-000015.pdf 0000790502-18-000015.rtf View HTML
January 7, 2019	SC 13G/A	An amendment to the SC 13G filing	0001193125-19-003657.pdf 0001193125-19-003657.rtf 0001193125-19-003657.xls View HTML
January 10, 2019	SC 13G/A	An amendment to the SC 13G filing	0000215457-19-000127.pdf 0000215457-19-000127.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax